Treatment Technologies & Insights (TTI), a digital health insights and real-world data company and developer of the #1 rated ePRO app for Oncology, Wave Health, announced today it has been named a 2024 ASCO® Breakthrough Abstract Award winner in recognition of their 8-clinic PRO-WAVE1 study conducted in Spain.

Interim results of a joint feasibility study conducted by TTI and the Wilmot Cancer Institute, involving the use of Wave Health, were selected for oral abstract presentation at the 2024 Oncology Nursing Society (ONS) Congress in Washington, D.C.

Presented at the 2024 ASCO Genitourinary Cancers Symposium, PRO-WAVE1 Research Results Showcase Opportunity to Operationalize the Patient-Provider Connection to Better Manage Cancer Care

The Wave Health digital health platform, used to collect patient symptom and quality of life information in an innovative research study, comprises two abstracts accepted to the 2023 ASCO Annual Meeting.

Inspire is the official publication of the NCODA Professional Student Organization. It engages young healthcare professionals with the latest news and insights in oncology pharmacy. Check out the latest issue of Inspire to read about how Wave Health is improving patient care!

This past week, CEO of TTI and creator of Wave Health, Matt Lashey, was featured on Entrepreneur Rx Podcast hosted by John Shufeldt, MD. Check out the interview here!

Recently, researchers at the University of Manchester and the Christie NHS Foundation Trust in the UK performed a systematic review of patient-facing cancer apps, in which Wave Health’s technology was validated as one of the leading ePRO platforms for oncology.